On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources

Medical Physics

Volumn 31, Issue 5, 2004, Pages 1040-1045

  Chan, Gordon H ^a   Nath, Ravinder ^b   Williamson, Jeffrey F ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

125I sources; Interstitial brachytherapy; Reference dosimetry; Task Group 43

Indexed keywords

MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY; RATE CONSTANTS;

ANISOTROPY PARAMETERS; DOSE RATE CONSTANTS; DOSIMETRIC PROPERTIES; INTERSTITIAL BRACHYTHERAPY; RADIAL DOSE FUNCTION; REFERENCE DOSIMETRY; TASK GROUPS; TREATMENT PLANNING;

DOSIMETRY;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; DOSIMETRY; ENERGY; INTERSTITIAL RADIATION; MONTE CARLO METHOD; PHOTON; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TECHNIQUE; TREATMENT PLANNING;

EID: 2442712723     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1690712     Document Type: Article

References (30)

1. R. Nath and N. Yue, "Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 BrachySeed™," Appl. Radiat. Isot. 55, 813-831 (2001).
2. J. F. Williamson, "Dosimetric characteristics of the DRAXIMAGE model LS-1 I-125 interstitial brachytherapy source design: A Monte Carlo investigation," Med. Phys. 29, 509-521 (2002).
3. 125I brachytherapy source," Appl. Radiat. Isot. 56, 805-813 (2002).
4. 125I BrachySeed™ model LS-1 source," Med. Phys. 29, 190-200 (2002).
5. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, " Med. Phys. 22, 209-234 (1995).
6. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, and R. Nath, "Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources," Med. Phys. 25, 2269-2270 (1998).
7. J. F. Williamson, "Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds," Med. Phys. 18, 776-786 (1991).
8. R. Wang and R. S. Sloboda, "EGS4 dosimetry calculation for cylindrically symmetric brachytherapy sources," Med. Phys. 23, 1459-1465 (1996).
9. J. Halbleib, "Structure and operation of the ITS code system," in Monte Carlo Transport of Electrons and Photons, edited by T. M. Jenkins, W. R. Nelson, and A. Rindi (Plenum, New York, 1988), pp. 249-262.
10. J. Halbleib, R. P. Kensek, T. Mehlhorn, G. D. Valdez, S. M. Seltzer, and M. J. Berger, "ITS Version 3.0: The Integrated TIGER Series of Coupled Electron/Photon Monte Carlo Transport Codes," Report SAND91-1634, Sandia National Laboratories, Albuquerque, NM and Livermore, CA, 1992.
11. J. F. Williamson, "The accuracy of the line and point source approximation in Ir-192 implant dosimetry," Int. J. Radiat. Oncol., Biol., Phys. 12, 409-414 (1986).
12. 103Pd 'light seed' and derivation of the anisotropy constant based upon the linear quadratic model," Med. Phys. 29, 1120-1129 (2002).
13. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, "Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations," Med. Phys. 31, 633-674 (2004).
14. J. J. DeMarco, R. E. Wallace, and K. Boedeker, "An analysis of MCNP cross-sections and tally methods for low-energy photon emitters," Phys. Med. Biol. 47, 1321-1332 (2002).
15. 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code," Med. Phys. 30, 701-711 (2003).
16. 103Pd seeds with air kerma strength calibration based upon a primary national standard," Med. Phys. 27, 655-658 (2000).
17. A. S. Meigooni, K. Sowards, and M. Soldano, "Dosimetric characteristics of the InterSource103 palladium brachytherapy source," Med. Phys. 27, 1093-1100 (2000).
18. 125I brachytherapy source," Med. Phys. 27, 2168-2173 (2000).
19. C. C. Popescu, J. Wise, K. Sowards, A. S. Meigooni, and G. S. Ibbott, "Dosimetric characteristics of the Pharma Seed model BT-125-I source, " Med. Phys. 27, 2174-2181 (2000).
20. 125I brachytherapy source," Med. Phys. 27, 2278-2285 (2000).
21. 103Pd brachytherapy source," Med. Phys. 28, 2568-2275 (2001).
22. T. D. Solberg, J. J. DeMarco, G. Hugo, and R. E. Wallace, "Dosimetric parameters of three new solid core I-125 brachytherapy sources," J. Appl. Clin. Med. Phys. 3, 119-134 (2002).
23. 125I brachytherapy source," Med. Phys. 29, 939-942 (2002).
24. 125I brachytherapy source," Med. Phys. 29, 2152-2158 (2002).
25. 103Pd-model Pd-1," Med. Phys. 29, 2433-2434 (2002).
26. A. S. Meigooni, H. Zhang, C. Perry, S. A. Dini, and R. A. Koona, "Theoretical and experimental determination of dosimetric characteristics for brachyseed™ Pd-103, model Pd-1, source," Appl. Radiat. Isot. 58, 533-541 (2003).
27. R. K. Das, D. Keleti, Y. Zhu, A. S. Kirov, A. S. Meigooni, and J. F. Williamson, "Validation of Monte Carlo dose calculations near I-125 brachytherapy sources in the presence of bounded tissue heterogeneities," Int. J. Radiat. Oncol., Biol., Phys. 38, 843-853 (1995).
28. 169Yb brachytherapy sources: An EGS4 Monte Carlo study," Phys. Med. Biol. 43, 1557-1566 (1998).
29. 192Ir brachytherapy sources: An EGS4 Monte Carlo study," Phys. Med. Biol. 45, 703-717 (2000).
30. R. Capote, E. Mainegra, and E. Lopez, "Anisotropy functions for low energy interstitial brachytherapy sources: An EGS4 Monte Carlo study," Phys. Med. Biol. 46, 135-150 (2001).